Drug General Information
Drug ID
D04QJY
Former ID
DNC012015
Drug Name
KELATORPHAN
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533380]
Structure
Download
2D MOL

3D MOL

Formula
C14H18N2O5
Canonical SMILES
CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)CC(=O)NO
InChI
1S/C14H18N2O5/c1-9(14(19)20)15-13(18)11(8-12(17)16-21)7-10-5-3-2-4-6-10/h2-6,9,11,21H,7-8H2,1H3,(H,15,18)(H,16,17)(H,19,20)/t9-,11+/m0/s1
InChIKey
OJCFZTVYDSKXNM-GXSJLCMTSA-N
PubChem Compound ID
Target and Pathway
Target(s) Aminopeptidase N Target Info Inhibitor [533380]
Glutamyl aminopeptidase Target Info Inhibitor [533380]
BioCyc Pathway Glutathione-mediated detoxification
KEGG Pathway Glutathione metabolism
Metabolic pathways
Renin-angiotensin system
Hematopoietic cell lineagehsa04614:Renin-angiotensin system
NetPath Pathway IL2 Signaling Pathway
Pathway Interaction Database C-MYB transcription factor network
PathWhiz Pathway Glutathione Metabolism
Reactome Metabolism of Angiotensinogen to AngiotensinsR-HSA-2022377:Metabolism of Angiotensinogen to Angiotensins
WikiPathways Metabolism of Angiotensinogen to Angiotensins
Cardiac Progenitor Differentiation
miR-targeted genes in squamous cell - TarBase
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in leukocytes - TarBase
Glutathione metabolismWP2729:Metabolism of Angiotensinogen to Angiotensins
References
Ref 533380J Med Chem. 1988 Sep;31(9):1825-31.Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.
Ref 533380J Med Chem. 1988 Sep;31(9):1825-31.Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.